| Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy (NCT05152927) | University of California, San Francisco | 2022-01-10 |
| Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer (NCT04807166) | Wenjun Cheng | 2021-08-24 |
| Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer (NCT04519151) | Sheba Medical Center | 2021-04-12 |
| Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer (NCT04556071) | Xiaoxiang Chen | 2020-11-06 |
| Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer (NCT04566952) | Xiaoxiang Chen | 2020-10-28 |
| HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors (NCT03911388) | M.D. Anderson Cancer Center | 2019-09-12 |
| A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma (NCT04008082) | Eisai Co., Ltd. | 2019-05-14 |
| Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma (NCT04124198) | Christian von Buchwald | 2019-03-01 |
| Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer (NCT03562897) | Catalysis SL | 2018-10-25 |
| Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors (NCT03037385) | Hoffmann-La Roche | 2017-03-17 |
| BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities (NCT03072472) | South Tyneside and Sunderland NHS Foundation Trust | 2017-02-14 |
| Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors (NCT02909452) | Syndax Pharmaceuticals | 2016-09-20 |
| Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors (NCT02897778) | Syndax Pharmaceuticals | 2016-08-24 |
| HR Versus RFA for HCC in Patients With PHT (NCT02192671) | Guangxi Medical University | 2015-05-01 |
| Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial (NCT01995942) | Royal Marsden NHS Foundation Trust | 2013-06-07 |
| Intended Use Study of the BD SurePath Plus™ Pap (NCT01234480) | Becton, Dickinson and Company | 2010-09-01 |
| Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) (NCT01009593) | Abbott | 2010-01-01 |
| Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks (NCT01037049) | Royal Marsden NHS Foundation Trust | 2009-10-16 |
| A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer (NCT00672009) | Cedars-Sinai Medical Center | 2008-04-01 |
| Low Rectal Cancer Study (MERCURY II) (NCT02005965) | Royal Marsden NHS Foundation Trust | 2007-08-13 |
| Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin (NCT00481936) | Sesen Bio, Inc. | 2007-05-01 |
| Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED) (NCT00337428) | Merck Sharp & Dohme LLC | 2006-05-01 |
| Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025) (NCT00325130) | Merck Sharp & Dohme LLC | 2006-04-01 |
| Vorasidenib Expanded Access Program (NCT05592743) | Servier | |